CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nov. 30, 2020– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a…
Home ยป
National study reveals new insights into avoidable harm in primary care
A national study of general practices in England has revealed the frequency of incidents of significant avoidable harm in primary…
Primary care experts produce guidance for limiting the psychological impacts of coronavirus
New guidance published in the BMJ today during Mental Health Awareness Week has outlined guidance for primary care workers on…
Decline in primary care visits continued after ACA
The long-term decrease in primary care contact was not interrupted following implementation of the Affordable Care Act (ACA), according to…
CymaBay Therapeutics Announces Seladelpar Granted Breakthrough Therapy Designation by the FDA for the Treatment of Primary Biliary Cholangitis
NEWARK, Calif., Feb. 15, 2019 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), today announced that the U.S. Food and…